ResearcherUniversidad Complutense de MadridActive in the last 2 years
José Manuel Asencio
Matched on ORCID iD 0000-0002-7533-5513; OpenAlex author ID A5010016916. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 5
- Surgical treatment of liver metastasis from pancreatic cancer. Co-author DOI 10.1016/j.suronc.2025.102308↗
- Neoadjuvant therapy impact in early pancreatic cancer: "bioborderline" vs. "non-bioborderline". Last author DOI 10.14701/ahbps.22-023↗
- Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades. Last author DOI 10.14701/ahbps.2021.25.2.179↗
- ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer. First author DOI 10.1016/j.ctro.2020.05.005↗
- ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer. Co-author DOI 10.1016/j.radonc.2020.03.040↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrés Jesús Muñoz Martín · 2 shared papers, 2021–2022 · strength 0.33
- Álvaro Gregorio Morales Taboada · 2 shared papers, 2021–2022 · strength 0.33
- Philip M. Poortmans · 2 shared papers, 2020 · strength 0.24
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic canc… DOI 10.1016/j.ctro.2020.05.005↗
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer. DOI 10.1016/j.radonc.2020.03.040↗
- Felipe Ángel Calvo · 2 shared papers, 2020 · strength 0.24
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic canc… DOI 10.1016/j.ctro.2020.05.005↗
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer. DOI 10.1016/j.radonc.2020.03.040↗
- Robert C Krempien · 2 shared papers, 2020 · strength 0.24
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic canc… DOI 10.1016/j.ctro.2020.05.005↗
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer. DOI 10.1016/j.radonc.2020.03.040↗
- Marco Krengli · 2 shared papers, 2020 · strength 0.24
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic canc… DOI 10.1016/j.ctro.2020.05.005↗
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer. DOI 10.1016/j.radonc.2020.03.040↗
- Frank W. Hensley · 2 shared papers, 2020 · strength 0.24
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic canc… DOI 10.1016/j.ctro.2020.05.005↗
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer. DOI 10.1016/j.radonc.2020.03.040↗
- Falk Roeder · 2 shared papers, 2020 · strength 0.24
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic canc… DOI 10.1016/j.ctro.2020.05.005↗
- Paper ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer. DOI 10.1016/j.radonc.2020.03.040↗
- José Manuel Ramia · 1 shared paper, 2025 · strength 0.18
- Mario Serradilla Martin · 1 shared paper, 2025 · strength 0.18
- Fernando Rotellar · 1 shared paper, 2025 · strength 0.18
- Mar Achalandabaso Boira · 1 shared paper, 2025 · strength 0.18
- Víctor López‐López · 1 shared paper, 2025 · strength 0.18
- Gerardo Blanco‐Fernández · 1 shared paper, 2025 · strength 0.18
- Eva M. Montalbá Orón · 1 shared paper, 2025 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.